MF
AUPH icon

Magnetar Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Magnetar Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199K Sell
11,739
-55,887
-83% -$893K ﹤0.01% 942
2026
Q1 		$1M Buy
67,626
+52,141
+337% +$762K 0.01% 477
2025
Q4 		$247K Sell
15,485
-462
-3% -$6.55K ﹤0.01% 748
2025
Q3 		$176K Buy
+15,947
New +$174K ﹤0.01% 788

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Magnetar Financial's AUPH Position: Q2 2026 in Review

Magnetar Financial reduced its Aurinia Pharmaceuticals (AUPH) stake by 83% in Q2 2026, selling an estimated $893K and leaving 11,739 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #942.

Magnetar Financial first reported a position in AUPH in Q3 2025 and has held it in 4 quarters since. The position peaked at $1M in Q1 2026. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Magnetar Financial held 11,739 shares of Aurinia Pharmaceuticals worth $199K as of Q2 2026.
  • Magnetar Financial sold 55,887 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $893K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #942 holding.
  • Magnetar Financial first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Magnetar Financial's Aurinia Pharmaceuticals position peaked at $1M in Q1 2026.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.